Preview

Journal of oncology: diagnostic radiology and radiotherapy

Advanced search

Evaluation of Sentinel Lymph Node Identification and Localization Using Ultrasound and Radionuclide Technologies in Breast Cancer Patients

https://doi.org/10.37174/2587-7593-2025-8-4-96-104

Abstract

Purpose: To study the diagnostic capabilities of the ultrasonic contrast agent sulfur hexafluoride in the detection of sentinel lymph nodes in patients with breast cancer; to assess the cordance of radioisotope and ultrasound techniques in the detection of sentinel lymph nodes.

Materials and methods: In this study included 152 patients with breast cancer (clinical stages T1‑3N0‑1M0), mean age 52.0±12.5 years. For the method of detecting SLN with ultrasound contrast, the drug Sonovue (Bracco Swiss, SA, Switzerland) was used.

Discussion: The frequency of sentinel lymph node detection using ultrasound contrast in the first and second groups was 97.6% and 89.9%, respectively, with the use of radiopharmaceuticals, 90.4% and 87%, respectively. The cordance of the two methods was 91%. Metastases in the sentinel lymph nodes were detected in 44 cases (28.9%). The detection rate of metastatic sentinel lymph nodes with ultrasound contrast was 95.5%, using a radiopharmaceutical — 88.6%.

Conclusion: The technique of sentinel lymph node detection using ultrasound contrast in breast cancer is characterized by simplicity and speed of execution, and high detection rates allow it to be used as an independent technology in axillary staging.

About the Authors

Yu. V. Bikeev
National medical research center for obstetrics, gynecology and perinatology named after academician V.I.Kulakov of the Ministry of healthcare of the Russian Federation
Russian Federation

Yury V. Bikeev

+7(495)531-44-44

4, Academica Oparina, Moscow, 117198


Competing Interests:

Not declared



M. V. Rodionova
National medical research center for obstetrics, gynecology and perinatology named after academician V.I.Kulakov of the Ministry of healthcare of the Russian Federation
Russian Federation

Maria V. Rodionova

4, Academica Oparina, Moscow, 117198


Competing Interests:

Not declared



A. N. Sencha
National medical research center for obstetrics, gynecology and perinatology named after academician V.I.Kulakov of the Ministry of healthcare of the Russian Federation; N.I. Pirogov Russian National Research Medical University
Russian Federation

Alexandr N. Sencha

4, Academica Oparina, Moscow, 117198;  

1, Ostovityanova, Moscow, Russia, 117513


Competing Interests:

Not declared



I. V. Kolyadina
National medical research center for obstetrics, gynecology and perinatology named after academician V.I.Kulakov of the Ministry of healthcare of the Russian Federation; Russian Medical Academy of Continuing Professional Education
Russian Federation

 Irina V. Kolyadina

4, Academica Oparina, Moscow, 117198;

2/1,Barricadnaya, Moscow, 125993


Competing Interests:

Not declared



V. V. Rodionov
National medical research center for obstetrics, gynecology and perinatology named after academician V.I.Kulakov of the Ministry of healthcare of the Russian Federation
Russian Federation

Valery V. Rodionov

4, Academica Oparina, Moscow, 117198


Competing Interests:

Not declared



V. V. Kometova
National medical research center for obstetrics, gynecology and perinatology named after academician V.I.Kulakov of the Ministry of healthcare of the Russian Federation
Russian Federation

Vlada V. Kometova

4, Academica Oparina, Moscow, 117198


Competing Interests:

Not declared



N. A. Zaytsev
National medical research center for obstetrics, gynecology and perinatology named after academician V.I.Kulakov of the Ministry of healthcare of the Russian Federation
Russian Federation

Nikita A. Zaytsev

4, Academica Oparina, Moscow, 117198


Competing Interests:

Not declared



References

1. Puig Carlos A, et al. National Trends in the Use of Neoadju vant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study. Annals of surgical oncology. 2017;24(5):1242-50. https://doi.org/10.1245/s10434-016-5733-y

2. Esposito E, Di Micco R, Gentilini OD. Sentinel node biopsy in early breast cancer. A review on recent and ongoing random ized trials. Breast (Edinburgh, Scotland), 2017;36:14-9. https://doi.org/10.1016/j.breast.2017.08.006

3. Manca Gianpiero, et al. Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies. Clinical Nuclear Med. 2016;41(2):126-33. https://doi.org/10.1097/RLU.0000000000000985

4. Vanni Gianluca, et al. Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 Patients. Anticancer Res. 2020;40(12): 7119-25. https://doi.org/10.21873/anticanres.14741

5. Bing AU, et al. Pooled long-term outcomes from two random ized trials of axillary node sampling with axillary radiothera py versus axillary node clearance in patients with operable node-positive breast cancer. British J Surg. 2016;103(1):81-7. https://doi.org/10.1002/bjs.9952

6. de Boniface, Jana, et al. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases. New England J Med. 2024;390(13):1163-75. https://doi.org/10.1056/NEJMoa2313487

7. Giuliano AE, Ballman KV, McCall L, et al. Effect of Axillary Dis section vs No Axillary Dissection on 10-Year Overall Survival Among Women with Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-26. https://doi.org/10.1001/jama.2017.11470

8. Liu Jieqiong, et al. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemo therapy: an analysis from the NCDB. Oncotarget. 2016;7(17): 24848 59. https://doi.org/10.18632/oncotarget.6664

9. Portnoy SM, Kuznetsov AV, et al. Sentinel lymph node biopsy using fluorescent lymphography in сТ1 4N0M0: breast cancer patients: high diagnostic capabilities. Voprosy oncologii. 2019;65(2):243-49.

10. Krag D N, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surgical oncology. 1993;2(6):335-9; discussion 340. https://doi.org/10.1016/0960-7404(93)90064-6

11. Krivorotko PV, Novikov SN, Tabagua TT, et al. Method for determining sentinel lymph nodes in breast cancer using radioisotope and/or fluorescence techniques. А textbook for doctors and students in the system of higher and additional professional education.St. Petersburg. 2024.

12. Bargon Claudia A, et al. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial. Annals of Surg. 2022;276(5):913-20. https://doi.org/10.1097/SLA.0000000000005633.

13. Omoto Kiyoka, et al. Sentinel node detection in breast cancer using contrast-enhanced sonography with 25 % albumin-Initial clinical experience. Journal of clinical ultrasound: JCU. 2006;34(7):317-26. https://doi.org/10.1002/jcu.20241

14. Sever A, et al. Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-en hanced ultrasonography in patients with breast cancer. The British J Surg. 2009;96(11):1295-9. https://doi.org/10.1002/bjs.6725

15. Cui Qiuxia, et al. Contrast-enhanced ultrasound-guided sentinel lymph node biopsy in early-stage breast cancer: a prospective cohort study. World J Surg Oncol. 2023 8 May;21(1):143. https://doi.org/10.1186/s12957-023-03024-7

16. Reimer Toralf, et al. Axillary Surgery in Breast Cancer — Pri mary Results of the INSEMA Trial. New England J Med. 2025;392(11):1051-64. https://doi.org/10.1056/NEJMoa2412063

17. Classe Jean-Marc, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;173(2): 343-52. https://doi.org/10.1007/s10549 018 5004 7

18. Zheng Mingjie, et al. Optimal Selection of Imaging Exam ination for Lymph Node Detection of Breast Cancer With Different Molecular Subtypes. Frontiers in Oncology. 13 Jul. 2022;12:762906. https://doi.org/10.3389/fonc.2022.762906

19. Krivorotko PV, Kanaev SV, et al. Methodological problems of sentinel lymph node biopsy in patients with breast cancer. Voprosy oncologi. 2015;61(3):418-23.

20. Petrovsky AV, Afanaseva KV, Goncharov MO, et al. Use various radiopharmaceuticals in sentinel lymph node biopsy in patients with breast cancer. Radiation oncology and nuclear medicine. 2013(1):85-89.3.

21. Li Juan, et al. How Pre-operative Sentinel Lymph Node Con trast-Enhanced Ultrasound Helps Intra-operative Sentinel Lymph Node Biopsy in Breast Cancer: Initial Experience. Ul trasound in Medicine & Biology. 2019;45(8):1865-73. https://doi.org/10.1016/j.ultrasmedbio.2019.04.006

22. Zhong Jieyu, et al. Contrast-Enhanced Ultrasound-Guided Fine-Needle Aspiration for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. Ultrasound in Medicine & Biology. 2018;44(7):1371-78. https://doi.org/110.1016/j.ultrasmedbio.2018.03.005


Review

For citations:


Bikeev Yu.V., Rodionova M.V., Sencha A.N., Kolyadina I.V., Rodionov V.V., Kometova V.V., Zaytsev N.A. Evaluation of Sentinel Lymph Node Identification and Localization Using Ultrasound and Radionuclide Technologies in Breast Cancer Patients. Journal of oncology: diagnostic radiology and radiotherapy. 2025;8(4):96-104. (In Russ.) https://doi.org/10.37174/2587-7593-2025-8-4-96-104

Views: 260

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7593 (Print)
ISSN 2713-167X (Online)